Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

boostAGErx vs MyFastRx

boostAGErx
Graded #183

Lower grade

vs+0.6000000000000085
MyFastRx
Graded #172

Higher grade

The verdict

MyFastRx takes it — 67.4/100 to 66.8/100, but only just.

MyFastRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. MyFastRx is a cash-pay compounded-GLP-1 platform built around fast approval and discounted multi-month bundles. boostAGErx is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMyFastRx +1
74
75
Dose & formulationboostAGErx +5
77
72
Clinical oversightboostAGErx +8
74
66
Labs & monitoringEven
52
52
FulfillmentMyFastRx +14
69
83
Contract termsMyFastRx +16
25
41
boostAGErx · left barMyFastRx · right bar

The numbers

MetricboostAGErxMyFastRx
WeighScore66.8/10067.4/100
GradeCC
Scorecard rank#183#172
Semaglutide$95/mo (starting dose, compounded)$169/mo
Tirzepatide$95/mo (starting dose, compounded)$249/mo
CoverageCoverage not publishedAll 50 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
boostAGErx

Graded #183 · C

Strengths

  • Compounded GLP-1 starting around $95/mo (12-month plan paid upfront)
  • Free shipping and clinical evaluation included
  • Membership fee refunded in full if you're not approved
  • Also offers peptide therapy such as sermorelin
  • 100% online with licensed providers — no clinic visit

Where it loses points

  • Headline $95/mo requires a 12-month upfront commitment; actual price varies by product/plan
  • Compounded medications are non-refundable once dispensed
  • Pharmacy partner not named on the site
  • Not LegitScript-certified (no certification displayed)
  • States of operation not published
MyFastRx

Graded #172 · C

Strengths

  • Aggressive 12-month bundle pricing — $99/mo semaglutide, $149/mo tirzepatide
  • LegitScript certified
  • All doses priced the same — no cost escalation as you titrate up
  • First-month promo discount lowers the trial barrier

Where it loses points

  • States served not disclosed — only 'multiple states' / 'licensed U.S. providers'
  • Corporate address and medical director not published
  • Pharmacy partner not named — only 'state-licensed pharmacies'
  • Cash-pay only — no insurance billing
  • Bundle savings require a large upfront commitment (12 months billed at once)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard